TFPI Polyclonal Antibody, Cy5.5 Conjugated
Product Specifications
Background
Inhibits factor X (X (a) ) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.
Synonyms
EPI; TFI; LACI; TFPI1; Tissue factor pathway inhibitor; TFPI; Extrinsic pathway inhibitor; Lipoprotein-associated coagulation inhibitor
Gene ID
7035
Swiss Prot
P10646
Cellular Locus
Secreted
Host
Rabbit
Cross Reactivity
Mouse, Rat
Immunogen
101-200/304
Target
TFPI
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5.5
Source
KLH conjugated synthetic peptide derived from human TFPI
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
675nm/694nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
7035
Predicted Cross Reactivity
Human, Cow, Pig, Horse, Rabbit
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6275711-01 0.2 mL
ASPHD2, ID (ASPHD2, Aspartate beta-hydroxylase domain-containing protein 2) (APC)
Ask
View Details MBS6275711-02 5x 0.2 mL
ASPHD2, ID (ASPHD2, Aspartate beta-hydroxylase domain-containing protein 2) (APC)
Ask
View Details 